Clinical investigation of medicinal products used in the treatment of osteoarthritis

Current effective version

PDF iconRevision 1 - Adopted guideline

Reference numberCPMP/EWP/784/97 Rev. 1
Effective from01/08/2010
KeywordsOsteoarthritis, symptom modifying drugs, structure modifying drugs, non-steroidal anti-inflammatory drugs (NSAIDs), clinical development
DescriptionThis document provides guidance on the clinical evaluation of medicinal products in the treatment of osteoarthritis.

Document history

Revision 1

Current version

PDF iconAdopted guideline

PDF iconOverview of comments

Draft guideline

PDF iconConcept paper

In operation: 01/08/2010–present

Published: 01/02/2010

Published: 23/04/2009

Published: 24/04/2008

Related content

How useful was this page?

Add your rating